EGFR and non-small cell lung carcinoma: The country is an imperfect predictor for shared genetic background, but previous experience (such as in non-small cell lung carcinoma, with a high prevalence of EGFR mutations in East Asian patients compared to Western or South Asian patients [151]) indicates that it is a potential confounder that needs to be addressed.